Diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: "Intervention group: " included 50 patients will receive bread containing purple( that has already been confirmed technically by its theological, physico-chemical and Sensory propertie
Sponsors
Azad University
Eligibility
Sex/Gender
All
Age
30 Years to 64 Years
Inclusion criteria
Inclusion criteria: Age range between 30-64 years old, Body Mass Index(BMI), range between 19 and 35 kg per m2, Diabetic patients referring to diabetes mellitus (known as diabetes mellitus and clinician) Fasting blood glucose = 125mg / dl.
Exclusion criteria
Exclusion criteria: Patients receiving insulin therapy; Patients with cardiovascular, renal, hepatic, hematological, hypothyroidism and convulsion diseases; Patients with a history of gallstones or gallbladder surgery; Patients under estrogen, steroid, beta-blocker and thiazide therapy; Women planning for pregnancy; pregnant women; breast-feeding women. The use of E and C supplements of omega 3 at least 6 months before sampling, Smoking and narcotics as well as those who have not been used during two weeks of training,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: At the beginning of the study, the end of the second and fourth week. Method of measurement: Blood glucose level will be determined in laboratory by commercial standard kit.;Triglyceride. Timepoint: At the beginning of the study, the end of the second and eight week. Method of measurement: Blood triglyceride level will be determined in laboratory by commercial standard kit.;(HDL) High-density lipoprotein. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Blood HDL level will be determined in laboratory by commercial standard kit.;Low-density lipoprotein (LDL). Timepoint: At the beginning of the study, the end of the second and fourth week. Method of measurement: Blood LDL level will be determined in laboratory by commercial standard kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Diastolic blood pressure. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Mercurial sphygmomanometer.;Liver Enzymes (Alanine Aminotransferase,Gamma-Glutamyl Transferase, Aspartate Amino Transferase) (AST, ALT, GGT). Timepoint: At the beginning of the study, the end of the eighth week. Method of measurement: Pars Azmon Kit.;Weight. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Scale.;Waist circumference. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Irresistible meter.;Systolic blood pressure. Timepoint: At the beginning of the study, the end of the second and eighth week. Method of measurement: Mercurial sphygmomanometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehri Delvarianzadeh
Shahroud University of Medical Sciences
Outcome results
None listed